Article dans une revue avec comité de lecture

Tournay, Virginie, Emmanuelle Rial-Sebbag, Doerte Bemme, Aurélie Mahalatchimy, Céline Granjou, Séverine Louvel and Anne Cambon-Thomsen. 2013. "Producing 'Human Elements Based Medical Technologies' in Biotech Companies: Some Ethical and Organisational Ingredients for Innovative Cooking." Science, technology and society 18 (1): 93-114.

Tournay, Virginie, Alex Faulkner, Aurélie Mahalatchimy and Emmanuelle Rial-Sebbag. 2012. "The Legal Landscape for Advanced Therapies : Material and Institutional Implementation of European Union Rules in France and United Kingdom." Journal of Law and Society 39 (1): 25-42.

Mahalatchimy, Aurélie, Emmanuelle Rial-Sebbag, Virginie Tournay and Alex Faulkner. 2012. "The Legal Landscape for Advanced Therapies: Material and Institutional Implementation of European Union Rules in France and the United Kingdom." Journal of Law and Society 39 (1): 131-149.

Article dans une revue sans comité de lecture

Tournay, Virginie, Anne Cambon-Thomsen, Anne-Marie Duguet, Nathalie De Grove-Valdeyron, Aurélie Mahalatchimy, Emmanuelle Rial-Sebbag and Florence Taboulet. 2012. "The European Medicines Agency : A public Health European Agency ?" Medicine and Law Journal 31 (1): 25-42.

Tournay, Virginie, Anne Cambon-Thomsen, Anne-Marie Duguet, Nathalie De Grove-Valdeyron, Aurélie Mahalatchimy, Emmanuelle Rial-Sebbag and Florence Taboulet. 2012. "The European Medicines Agency : A public Health European Agency ?" Medicine and Law Journal 31 (1): 25-42.

Mahalatchimy, Aurélie, Emmanuelle Rial-Sebbag, Nathalie De Grove-Valdeyron, Virginie Tournay, Anne Cambon-Thomsen, Anne-Marie Duguet and Florence Taboulet. 2012. "The European Medicines Agency: A public Health European Agency?" Medicine and Law Journal 31 (1): 25-42.

Mahalatchimy, Aurélie, Emmanuelle Rial-Sebbag, Virginie Tournay and Alex Faulkner. 2011. "Does the French Bioethics Law create a 'moral exception' to the use of human cells for health ?: A legal and organisational issue." Dilemata 3 (7): 17-37.

Tournay, Virginie, Alex Faulkner, Aurélie Mahalatchimy and Emmanuelle Rial-Sebbag. 2011. "Does the French Bioethics Law create a 'moral exception' to the use of human cells for health ?" Dilemata.

Tournay, Virginie, Alex Faulkner, Aurélie Mahalatchimy and Emmanuelle Rial-Sebbag. 2011. "Does the French Bioethics Law create a 'moral exception' to the use of human cells for health ?" Dilemata no. 7:17-37.

Communication orale sans acte dans un congrès international ou national

Tournay, Virginie, Anne-Marie Duguet, Aurélie Mahalatchimy and Emmanuelle Rial-Sebbag. 2010. "Transformer des cellules souches embryonnaires : quels enjeux éthiques et juridiques." Paper presented at the 18th world Congress on Medical Law, Zagreb, CROATIA, August 8-8.

Tournay, Virginie, Emmanuelle Rial-Sebbag and Aurélie Mahalatchimy. 2010. "Legal and ethical controversies around medical uses of stem cells: Is Medical Ethics Really in the Best interest of the Patient?" Paper presented at the Extra Session on Stem Cells Ethics, Uppsala, SWEDEN, June 14-16.